ALSP

ALSP Inc. is a privately held company based in San Diego, California, developing small molecule drugs for treating neurodegenerative diseases, initially focused on traumatic brain injury (TBI). Each year traffic accidents, falls, assaults, whether military or domestic, and sports injuries account for millions of incidences of traumatic injury to the brain requiring costly treatment in the emergency room and intensive care units with hundreds of thousands requiring hospitalization. These injuries initiate an inflammatory reaction that can cause a lesion in the brain that, depending on severity, often results in lasting brain deficits that can severely impair the productivity and quality of life for the individual sustaining the injury. These deficits include, but are not limited to, impaired memory, reduced attention span and mental flexibility, an inability to focus mentally, and impaired motor skills. The financial burden resulting from these injuries ranges into the tens of billions..

Also known as: ALSP Inc.

Primary location: La Jolla United States